FDA Panel Urges Restrictions on 2 Asthma Drugs
This is a discussion on FDA Panel Urges Restrictions on 2 Asthma Drugs within the Other Clinical Pharmacy News forum, part of the Industry News and Updates category; Experts urged the FDA to communicate to doctors that Serevent and Foradil inhalers should not be used alone. WebMD Health ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
12-12-2008, 02:37 PM
|
|||
|
|||
FDA Panel Urges Restrictions on 2 Asthma Drugs
Experts urged the FDA to communicate to doctors that Serevent and Foradil inhalers should not be used alone.
WebMD Health News More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| FDA Panel Asks: Are Asthma Drugs Safe? | industry_news | Other Clinical Pharmacy News | 0 | 12-10-2008 09:55 PM |
| Asthma Severity and Perceived Asthma Control Linked With Mortality Risk | industry_news | Other Clinical Pharmacy News | 0 | 09-23-2008 10:45 AM |
| Nimotop UM restrictions | participant1 | Managed Care Issues for Oral Drugs | 2 | 08-27-2008 10:52 AM |
| UK Agency Urges Doctors to Cut Antibiotics | industry_news | Other Clinical Pharmacy News | 0 | 07-24-2008 08:29 AM |
| FDA panel backs added risk review on diabetes drugs | industry_news | Biotechnology News | 0 | 07-03-2008 04:02 PM |
© 2008 DrugManagementForum™ powered by |
 |